Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
The 15 selected fellows gain mentorship and access to Caris' molecular data from over 484,000 patients to advance clinically meaningful precision oncology research.
- On Nov. 21, 2025, Caris Life Sciences announced selection of 15 physician-scientists for the 2025/2026 Caris Precision Oncology Alliance Fellows Forum in Irving, Texas.
- The Caris Precision Oncology Alliance Fellows Forum provides early-career oncologists, physician-scientists in their first or second year of oncology fellowship, mentorship and access to molecular data, said James Hamrick.
- Program participants will access Caris' CODEai database covering more than 484,000 patients and over 97 cancer institutions, plus attend guided tours of Blood and Tissue Labs in Phoenix and monthly virtual workshops.
- Fellows dedicate time monthly, participating in data analysis, seminars, and mentorship; `Investing in the next generation of oncology leaders allows us to advance research while also accelerating discoveries that will change how we diagnose and treat cancer`, said James Hamrick.
- Using comprehensive molecular profiling, Caris Life Sciences applies Whole Exome and Whole Transcriptome Sequencing with AI and machine learning analytics to build multimodal clinico-genomic analytic capability.
14 Articles
14 Articles
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris…
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris…
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris…
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris…
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris…
Caris Precision Oncology Alliance Fellows Forum Welcomes 2025/2026 Class
IRVING, Texas, Nov. 21, 2025 /PRNewswire/ -- Caris Life Sciences® (NASDAQ: CAI), a leading, patient-centric, next-generation AI TechBio company and precision medicine pioneer, today announced the selection of 15 physician-scientists to participate in its 2025/2026 Caris Precision Oncology Alliance (Caris…
Coverage Details
Bias Distribution
- 87% of the sources are Center
Factuality
To view factuality data please Upgrade to Premium







